» Articles » PMID: 24291274

Let-7g Improves Multiple Endothelial Functions Through Targeting Transforming Growth Factor-beta and SIRT-1 Signaling

Overview
Date 2013 Dec 3
PMID 24291274
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The present study aimed to explore the role of microribonucleic acid (miRNA) Let-7g in regulating endothelial functions.

Background: Derangement of miRNAs is implicated in the pathogenesis of cardiovascular diseases. Because the transforming growth factor (TGF)-β pathway plays a regulatory role in endothelial functions, miRNAs targeted at TGF-β signal cascade might affect vascular health.

Methods: Bioinformatics software predicted that Let-7g can influence the TGF-β pathway by targeting 3 genes. The Let-7g's effects on multiple endothelial functions were first tested in endothelial cells (ECs) and then in apolipoprotein E knockout mice. Blood samples from lacunar stroke patients were also examined to further support Let-7g's effects on human subjects.

Results: Let-7g was experimentally confirmed to knock down the THBS1, TGFBR1, and SMAD2 genes in the TGF-β pathway. PAI-I, one of the downstream effectors of the TGF-β pathway, was also down-regulated by Let-7g. Let-7g decreased EC inflammation and monocyte adhesion and increased angiogenesis via the TGF-β pathway. Furthermore, Let-7g reduced EC senescence through increasing SIRT-1 protein. Venous injection of Let-7g inhibitor into apolipoprotein E knockout mice caused overgrowth of vascular intima-media, overexpression of PAI-1, increased macrophage infiltration, and up-regulation of TGF-β downstream genes in the carotid arteries. Let-7g's beneficial effects on EC were reduced, whereas the TGF-β pathway was suppressed by ribonucleic acid interference. Restoration of the TGF-β pathway also attenuated the effects of Let-7g overexpression. Low serum levels of Let-7g were associated with increased circulating PAI-1 levels.

Conclusions: Decreased Let-7g levels impair endothelial function and increase the risks of cardiovascular diseases through targeting TGF-β and SIRT-1 signaling.

Citing Articles

Cellular Phenotypic Transformation During Atherosclerosis: The Potential Role of miRNAs as Biomarkers.

Wassaifi S, Kaeffer B, Zarrouk S Int J Mol Sci. 2025; 26(5).

PMID: 40076710 PMC: 11900927. DOI: 10.3390/ijms26052083.


Targeting PDGF/PDGFR Signaling Pathway by microRNA, lncRNA, and circRNA for Therapy of Vascular Diseases: A Narrow Review.

Ma C, Shi S, Zhang X, Xin G, Zou X, Li W Biomolecules. 2024; 14(11).

PMID: 39595622 PMC: 11592287. DOI: 10.3390/biom14111446.


Identification of Specific microRNAs in Adipose Tissue Affected by Lipedema.

Cione E, Michelini S, Abrego-Guandique D, Vaia N, Michelini S, Puleo V Curr Issues Mol Biol. 2024; 46(11):11957-11974.

PMID: 39590304 PMC: 11592672. DOI: 10.3390/cimb46110710.


TGFβ signaling pathways in human health and disease.

Chen P, Qin L, Simons M Front Mol Biosci. 2023; 10:1113061.

PMID: 37325472 PMC: 10267471. DOI: 10.3389/fmolb.2023.1113061.


microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation.

Desantis V, Potenza M, Sgarra L, Nacci C, Scaringella A, Cicco S Int J Mol Sci. 2023; 24(6).

PMID: 36982382 PMC: 10049145. DOI: 10.3390/ijms24065307.